These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 7280410)
21. Two or more intra AV nodal pathways in association with either a James or Kent extranodal bypass in 3 patients with paroxysmal supraventricular tachycardia. Spurrell RA; Krikler D; Sowton E Br Heart J; 1973 Feb; 35(2):113-22. PubMed ID: 4690532 [No Abstract] [Full Text] [Related]
22. [Paroxysmal supraventricular tachycardias due to re-entry via concealed retrograde atrio-His bypass (author's transl)]. Alboni P; Pedroni P; Malacarne C; Filippi L; De Lorenzi E; Masoni A G Ital Cardiol; 1981; 11(12):1871-82. PubMed ID: 7346291 [TBL] [Abstract][Full Text] [Related]
23. [Electrophysiologic demonstration of dual atrioventricular nodal pathways and final common pathway in a case of A-V nodal paroxysmal tachycardia. Considerations on the functional complexity of the A-V node (author's transl)]. Guaragna RF; Lentini G; Lombardi G; Piazzolla P; Bracchetti D G Ital Cardiol; 1981; 11(4):517-23. PubMed ID: 7286522 [TBL] [Abstract][Full Text] [Related]
24. [Pharmacology of anti-arrhythmic agents (author's transl)]. Hergueta G Folia Clin Int (Barc); 1975 Dec; 25(12):661-73. PubMed ID: 1220986 [No Abstract] [Full Text] [Related]
25. [Radiofrequency ablation of supraventricular tachycardias]. García Bolao I; Brugada J Rev Med Univ Navarra; 1998; 42(1):34-41. PubMed ID: 10420955 [TBL] [Abstract][Full Text] [Related]
26. Site of reentry in paroxysmal supraventricular tachycardia in man. Goldreyer BN; Bigger JT Circulation; 1971 Jan; 43(1):15-26. PubMed ID: 5540847 [No Abstract] [Full Text] [Related]
27. ECG indicators of accessory pathway involvement in paroxysmal supraventricular tachycardia. Belhassen B; Pelleg A; Ostzega E; Laniado S Isr J Med Sci; 1980 Aug; 16(8):581-7. PubMed ID: 7419378 [TBL] [Abstract][Full Text] [Related]
29. Clinical application of new concepts of parasystole, reflection, and tachycardia. Antzelevitch C Cardiol Clin; 1983 Feb; 1(1):39-50. PubMed ID: 6399992 [TBL] [Abstract][Full Text] [Related]
30. [Anti-arrhythmia stimulators in the treatment of paroxysmal tachycardia--principles of action and first clinical experiences]. Haładyj M; Suwalski K; Mojkowski W; Peczalski K; Stopczyk M Kardiol Pol; 1983; 26(7):601-9. PubMed ID: 6645156 [No Abstract] [Full Text] [Related]
31. Non-documented but induced supraventricular tachycardia: a new challenge or a new light?--author's reply. Lauschke J; Schneider R; Bänsch D Europace; 2016 Feb; 18(2):315. PubMed ID: 26521293 [No Abstract] [Full Text] [Related]
32. [Antiarrhythmic actions of disopyramide phosphate in patients with paroxysmal supraventricular tachycardia (author's transl)]. Satoh M; Sada T; Kuan-Min S; Kira Y; Sekine I; Okabe F; Ueda A; Ito T; Matsumoto S Kokyu To Junkan; 1981 May; 29(5):537-44. PubMed ID: 7313358 [No Abstract] [Full Text] [Related]
33. Electrophysiologic effects and therapeutic efficacy of intravenous flecainide for termination of paroxysmal supraventricular tachycardia. Gambhir DS; Bhargava M; Arora R; Khalilullah M Indian Heart J; 1995; 47(3):237-43. PubMed ID: 7558090 [TBL] [Abstract][Full Text] [Related]